vs
Side-by-side financial comparison of Astera Labs, Inc. (ALAB) and BALCHEM CORP (BCPC). Click either name above to swap in a different company.
BALCHEM CORP is the larger business by last-quarter revenue ($270.7M vs $270.6M, roughly 1.0× Astera Labs, Inc.). Astera Labs, Inc. runs the higher net margin — 16.6% vs 14.9%, a 1.7% gap on every dollar of revenue. On growth, Astera Labs, Inc. posted the faster year-over-year revenue change (91.8% vs 8.1%). Astera Labs, Inc. produced more free cash flow last quarter ($76.6M vs $33.8M). Over the past eight quarters, Astera Labs, Inc.'s revenue compounded faster (103.6% CAGR vs 7.5%).
Astera Labs, Inc. is an American fabless semiconductor manufacturer and artificial intelligence company. The company specializes in designing high-speed connectivity solutions for data centers and AI infrastructure. The company has been listed on the Nasdaq since March 2024.
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
ALAB vs BCPC — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $270.6M | $270.7M |
| Net Profit | $45.0M | $40.3M |
| Gross Margin | 75.6% | — |
| Operating Margin | 24.7% | 20.5% |
| Net Margin | 16.6% | 14.9% |
| Revenue YoY | 91.8% | 8.1% |
| Net Profit YoY | 82.0% | 8.7% |
| EPS (diluted) | $0.25 | $1.25 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $270.7M | ||
| Q4 25 | $270.6M | $263.6M | ||
| Q3 25 | $230.6M | $267.6M | ||
| Q2 25 | $191.9M | $255.5M | ||
| Q1 25 | $159.4M | $250.5M | ||
| Q4 24 | $141.1M | $240.0M | ||
| Q3 24 | $113.1M | $239.9M | ||
| Q2 24 | $76.8M | $234.1M |
| Q1 26 | — | $40.3M | ||
| Q4 25 | $45.0M | $39.2M | ||
| Q3 25 | $91.1M | $40.3M | ||
| Q2 25 | $51.2M | $38.3M | ||
| Q1 25 | $31.8M | $37.1M | ||
| Q4 24 | $24.7M | $33.6M | ||
| Q3 24 | $-7.6M | $33.8M | ||
| Q2 24 | $-7.5M | $32.1M |
| Q1 26 | — | — | ||
| Q4 25 | 75.6% | 35.6% | ||
| Q3 25 | 76.2% | 35.7% | ||
| Q2 25 | 75.8% | 36.4% | ||
| Q1 25 | 74.9% | 35.2% | ||
| Q4 24 | 74.0% | 36.0% | ||
| Q3 24 | 77.7% | 35.6% | ||
| Q2 24 | 77.9% | 35.5% |
| Q1 26 | — | 20.5% | ||
| Q4 25 | 24.7% | 19.8% | ||
| Q3 25 | 24.0% | 20.4% | ||
| Q2 25 | 20.7% | 20.1% | ||
| Q1 25 | 7.1% | 20.4% | ||
| Q4 24 | 0.1% | 19.8% | ||
| Q3 24 | -7.9% | 20.0% | ||
| Q2 24 | -31.7% | 19.6% |
| Q1 26 | — | 14.9% | ||
| Q4 25 | 16.6% | 14.9% | ||
| Q3 25 | 39.5% | 15.1% | ||
| Q2 25 | 26.7% | 15.0% | ||
| Q1 25 | 20.0% | 14.8% | ||
| Q4 24 | 17.5% | 14.0% | ||
| Q3 24 | -6.7% | 14.1% | ||
| Q2 24 | -9.8% | 13.7% |
| Q1 26 | — | $1.25 | ||
| Q4 25 | $0.25 | $1.21 | ||
| Q3 25 | $0.50 | $1.24 | ||
| Q2 25 | $0.29 | $1.17 | ||
| Q1 25 | $0.18 | $1.13 | ||
| Q4 24 | $1.23 | $1.03 | ||
| Q3 24 | $-0.05 | $1.03 | ||
| Q2 24 | $-0.05 | $0.98 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.6M | $72.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.4B | $1.3B |
| Total Assets | $1.5B | $1.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $72.9M | ||
| Q4 25 | $167.6M | $74.6M | ||
| Q3 25 | $140.4M | $65.1M | ||
| Q2 25 | $162.3M | $65.4M | ||
| Q1 25 | $86.4M | $49.9M | ||
| Q4 24 | $79.6M | $49.5M | ||
| Q3 24 | $126.1M | $73.7M | ||
| Q2 24 | $421.1M | $63.7M |
| Q1 26 | — | $1.3B | ||
| Q4 25 | $1.4B | $1.3B | ||
| Q3 25 | $1.3B | $1.3B | ||
| Q2 25 | $1.1B | $1.3B | ||
| Q1 25 | $1.0B | $1.2B | ||
| Q4 24 | $964.8M | $1.1B | ||
| Q3 24 | $889.6M | $1.2B | ||
| Q2 24 | $845.3M | $1.1B |
| Q1 26 | — | $1.7B | ||
| Q4 25 | $1.5B | $1.7B | ||
| Q3 25 | $1.4B | $1.7B | ||
| Q2 25 | $1.3B | $1.7B | ||
| Q1 25 | $1.1B | $1.6B | ||
| Q4 24 | $1.1B | $1.6B | ||
| Q3 24 | $983.1M | $1.6B | ||
| Q2 24 | $915.5M | $1.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $95.3M | $40.1M |
| Free Cash FlowOCF − Capex | $76.6M | $33.8M |
| FCF MarginFCF / Revenue | 28.3% | 12.5% |
| Capex IntensityCapex / Revenue | 6.9% | 2.3% |
| Cash ConversionOCF / Net Profit | 2.12× | 0.99× |
| TTM Free Cash FlowTrailing 4 quarters | $281.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $40.1M | ||
| Q4 25 | $95.3M | $67.3M | ||
| Q3 25 | $78.2M | $65.6M | ||
| Q2 25 | $135.4M | $47.3M | ||
| Q1 25 | $10.5M | $36.5M | ||
| Q4 24 | $39.7M | $52.3M | ||
| Q3 24 | $63.5M | $51.3M | ||
| Q2 24 | $29.8M | $45.0M |
| Q1 26 | — | $33.8M | ||
| Q4 25 | $76.6M | — | ||
| Q3 25 | $65.9M | — | ||
| Q2 25 | $133.3M | — | ||
| Q1 25 | $6.0M | — | ||
| Q4 24 | $24.3M | — | ||
| Q3 24 | $46.8M | — | ||
| Q2 24 | $28.5M | — |
| Q1 26 | — | 12.5% | ||
| Q4 25 | 28.3% | — | ||
| Q3 25 | 28.6% | — | ||
| Q2 25 | 69.5% | — | ||
| Q1 25 | 3.7% | — | ||
| Q4 24 | 17.2% | — | ||
| Q3 24 | 41.4% | — | ||
| Q2 24 | 37.1% | — |
| Q1 26 | — | 2.3% | ||
| Q4 25 | 6.9% | — | ||
| Q3 25 | 5.3% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 2.8% | — | ||
| Q4 24 | 10.9% | — | ||
| Q3 24 | 14.8% | — | ||
| Q2 24 | 1.7% | — |
| Q1 26 | — | 0.99× | ||
| Q4 25 | 2.12× | 1.72× | ||
| Q3 25 | 0.86× | 1.63× | ||
| Q2 25 | 2.64× | 1.23× | ||
| Q1 25 | 0.33× | 0.98× | ||
| Q4 24 | 1.61× | 1.56× | ||
| Q3 24 | — | 1.52× | ||
| Q2 24 | — | 1.40× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
